Health
Artificial Intelligence helps predict falls, creating safety system for patients
Solution alerts caregivers about unsteady gaits, making for prompt intervention. Trials in local healthcare institutions called promising. SINGAPORE, Jan. 3, 2024 /PRNewswire/ -- Applying AI technology to one of the main concerns in patient safety, Nanyang Polytechnic (NYP) and local medical te...
2024-01-03 16:00
2014
Guo Guangchang's New Year's Message: Steer Through the Rapids, Believe in the Future
HONG KONG, Jan. 3, 2024 /PRNewswire/ -- In the blink of an eye, 2023 is coming to an end. Thank you for your hard work and dedication. It has been a year of relentless efforts toward hope. After experiencing the three-year epidemic, many families have made plans for the new year from the beginni...
2024-01-03 11:35
6006
Bangkok Dusit Medical Services strengthens partnership with CNN focusing on global health issues and solutions
HONG KONG, Jan. 3, 2024 /PRNewswire/ -- Bangkok Dusit Medical Services Public
Company Limited (BDMS), the largest private healthcare network inThailand, is
continuing its long-term partnership with CNN International Commercial (CNNIC)
through the sponsorship ofVital Signs
2024-01-03 11:30
2302
Sciwind Biosciences Announces Positive Topline Results from Phase 3 Clinical Trial of Ecnoglutide (XW003), a Long-acting cAMP Signaling Biased GLP-1 Analog, in Adult Patients with Type 2 Diabetes in China
* Study participants receiving 0.6 and 1.2 mg ecnoglutide once weekly for 24 weeks achieved HbA1c reductions of 1.96 and 2.43% from baseline, respectively, compared to 0.87 % for placebo * In the 1.2 mg ecnoglutide cohort, 76.1% of participants achieved HbA1c ≤ 6.5% and 35.2% achieved HbA1c< ...
2024-01-03 10:00
2457
USANA Named No. 1 Vitamins and Dietary Supplements Brand in Philippines
Euromonitor honors USANA Philippines for fifth time MANILA, Philippines, Jan. 3, 2024 /PRNewswire/ -- USANA Health Sciences, Inc., a leader in the health and wellness industry, was named the number one vitamin and dietary supplement brand in Philippines* by Euromonitor. This marks the fifth tim...
2024-01-03 09:07
2019
Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
NATICK, Mass., Jan. 2, 2024 /PRNewswire/ -- Allorion Therapeutics ("Allorion"), a US andChina-based biotechnology company that focuses on the discovery of new small molecule drugs for treating cancer and autoimmune diseases, has entered into an exclusive option and global license agreement with A...
2024-01-02 22:00
1916
Novel Device Facilitates Successful No-Shave FUE Transplants for Long Hair with Ease
LOS ANGELES, Jan. 2, 2024 /PRNewswire/ -- A recent study published in the Clinical, Cosmetic and Investigational Dermatology journal reveals a groundbreaking advancement in hair transplantation, reports Dr U Hair and Skin Clinic. The research, titled "No-Shave Long Hair Follicular Unit Excision u...
2024-01-02 21:00
1733
Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval
SHANGHAI, Jan. 2, 2024 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), recently announced that it has successfully obtained Humanitarian Use Device (HUD) designation from the US FDA and approval ...
2024-01-02 20:30
2117
JW Therapeutics Announces Exclusive Collaboration with 2seventy bio for Autoimmune Disease CAR-T Therapy
SHANGHAI, Jan. 2, 2024 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, is pleased to announce an exclusive collaboration with 2seventy bio (NASDAQ: TSVT), for the c...
2024-01-02 20:15
2491
Gannex Announces Positive Interim Results from 52-Week Phase II Clinical Trial of Once-Daily ASC41 Tablet in Patients with Biopsy-Confirmed Non-alcoholic Steatohepatitis
--Up to 68.2% mean relative reduction in liver fat content from baseline in biopsy-confirmed non-alcoholic steatohepatitis (NASH) patients receiving 12-week treatment of ASC41 tablet --At Week 12, up to 93.3% patients achieved at least a 30% relative reduction in liver fat content from baseline ...
2024-01-02 20:06
2666
AXA enhances multiple employee benefits to promote work-life balance in the workplace
Paid co-parent leave significantly increased to 40 days with additional days paid caregiver and fertility leave, providing support to employees at different life stages HONG KONG, Jan. 2, 2024 /PRNewswire/ -- AXA has always advocated for a diverse and inclusive corporate culture and is committed...
2024-01-02 12:14
3434
Xinhua Silk Road: Xinhua-Yushu Wild Cordyceps Sinensis Price Index unveiled in Beijing
BEIJING, Jan. 2, 2024 /PRNewswire/ -- The Xinhua-Yushu Wild Cordyceps Sinensis
Price Index was officially released on Dec. 27th inBeijing, capital of China,
indicating the accelerated development of wild cordyceps sinensis industry
towards a new stage of digital, information and modern mode.
2024-01-02 10:06
2450
Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity
ROCKVILLE, Md. and SUZHOU, China, Jan. 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and o...
2024-01-02 08:00
9172
Demron by RST - Advanced Protection Against Today's Nuclear Threats
MIAMI, Jan. 2, 2024 /PRNewswire/ -- Radiation Shield Technologies (RST) proudly marks over two decades of innovation with Demron, a unique fabric designed to safeguard frontline personnel, including military, nuclear industry workers, emergency response teams, Hazmat Teams, firefighters, law enfo...
2024-01-02 08:00
1974
Cathay Insurance Vietnam and SAWAD Launch One-Stop "Dual Finance" Programme
HO CHI MINH CITY, Vietnam, Dec. 29, 2023 /PRNewswire/ -- Cathay Insurance Vietnam has partnered with SAWAD to launch a one-stop "Dual Finance" programme which allows customers to apply for the financial support, and at the same time, purchase separate mandatory insurance coverage in a streamlined...
2023-12-29 17:48
7113
ANAESTHESIOLOGIST HERO, DOCTOR'S QUICK THINKING SAVES CYCLIST'S LIFE DURING LEKAS NIGHT RIDE 2023
Off-duty doctor's decisive action and collaboration with fellow physician-cyclists lead to a successful resuscitation and life-saving measures. SELANGOR, MALAYSIA, Dec. 29, 2023 /PRNewswire/ -- In an extraordinary display of quick thinking and medical expertise, Dr. Shahridan Bin Mohd Fathil, an ...
2023-12-29 17:20
3239
Positive Results In The Interim Analysis Of The Clinical Trial Of Recbio's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines
TAIZHOU, China, Dec. 29, 2023 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that the novel adjuvanted recombinant shingles vaccine REC610 independently developed by the Company has recently achieved positive...
2023-12-29 12:33
2590
Clover Announces Positive Phase Ⅰ Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT)
--All CIT patients maintained platelet counts >75 x 109/L at 1-week following chemotherapy plus a single dose of SCB-219M, with durable responses through at least 3-weeks-- --Durable efficacy and PK profile expected to support convenient dosing interval of ≥2-weeks, compared to daily or weekly d...
2023-12-29 07:30
2455
HANSIZHUANG Sets Sail in Indonesia Market
* The 1st China anti-PD-1 monoclonal antibody successfully approved in Southeast Asia - * The 1st overseas approval of HANSIZHUANG, highlighting another major milestone of Henlius' global strategy after HANQUYOU - * Along with KGbio and other partners to develop and launch HANSIZHUANG in ov...
2023-12-28 21:51
3468
RemeGen's Pioneering RC88 Receives IND Approval from US FDA for Platinum-Resistant Recurrent Ovarian Cancer Treatment
YANTAI, China, Dec. 28, 2023 /PRNewswire/ -- RemeGen Co. Ltd.
2023-12-28 15:45
2253
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8873
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7709